J L Schwartz

Summary

Affiliation: Eastern Virginia Medical School
Country: USA

Publications

  1. ncbi request reprint Current contraceptive research
    Jill L Schwartz
    CONRAD, Arlington, VA, USA
    Perspect Sex Reprod Health 34:310-6. 2002
  2. doi request reprint Safety evaluation of 1% tenofovir gel in healthy men
    J L Schwartz
    Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Int J STD AIDS 20:384-6. 2009
  3. doi request reprint Comparative crossover study of the PATH Woman's Condom and the FC Female Condom
    Jill L Schwartz
    Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 78:465-73. 2008
  4. doi request reprint SILCS diaphragm: postcoital testing of a new single-size contraceptive device
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 78:237-44. 2008
  5. doi request reprint A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, Virginia 22209, USA
    Sex Transm Dis 35:414-9. 2008
  6. pmc A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, Virginia, United States of America
    PLoS ONE 6:e25974. 2011
  7. ncbi request reprint Fourteen-day safety and acceptability study of the universal placebo gel
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School EVMS, Arlington, VA 22209, USA
    Contraception 75:136-41. 2007
  8. ncbi request reprint Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study
    Jill L Schwartz
    Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 74:133-40. 2006
  9. ncbi request reprint Male tolerance of ACIDFORM gel
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 71:443-6. 2005
  10. pmc FemCap with removal strap: ease of removal, safety and acceptability
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 73:59-64. 2006

Detail Information

Publications14

  1. ncbi request reprint Current contraceptive research
    Jill L Schwartz
    CONRAD, Arlington, VA, USA
    Perspect Sex Reprod Health 34:310-6. 2002
  2. doi request reprint Safety evaluation of 1% tenofovir gel in healthy men
    J L Schwartz
    Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Int J STD AIDS 20:384-6. 2009
    ..TFV gel applied to the penis for seven days was well tolerated locally and systemically and it is unlikely that male partners exposed to small amounts of TFV gel will experience significant genital or systemic toxicity...
  3. doi request reprint Comparative crossover study of the PATH Woman's Condom and the FC Female Condom
    Jill L Schwartz
    Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 78:465-73. 2008
    ..The Program for Appropriate Technology in Health (PATH) Woman's Condom (WC) was developed in an effort to overcome these obstacles...
  4. doi request reprint SILCS diaphragm: postcoital testing of a new single-size contraceptive device
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 78:237-44. 2008
    ..This study was conducted to compare the effectiveness of a new, single-size silicone contraceptive diaphragm used with either spermicide [2% nonoxynol-9 (N-9)] or lubricant in preventing sperm from penetrating midcycle cervical mucus...
  5. doi request reprint A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, Virginia 22209, USA
    Sex Transm Dis 35:414-9. 2008
    ..This study evaluated the effect of a single dose and 5 additional consecutive daily doses of UC781 gel at concentrations of 0.1%, 0.25%, 1.0%, and 0% on urogenital irritation...
  6. pmc A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, Virginia, United States of America
    PLoS ONE 6:e25974. 2011
    ..Tenofovir (TFV) gel is being evaluated as a microbicide with pericoital and daily regimens. To inhibit viral replication locally, an adequate concentration in the genital tract is critical...
  7. ncbi request reprint Fourteen-day safety and acceptability study of the universal placebo gel
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School EVMS, Arlington, VA 22209, USA
    Contraception 75:136-41. 2007
    ..This study evaluated the effect of the so-called universal placebo compared to the polystyrene sulfonate (PSS) placebo on genital irritation...
  8. ncbi request reprint Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study
    Jill L Schwartz
    Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 74:133-40. 2006
    ..Cellulose sulfate (CS) is a noncytotoxic antifertility agent that exhibits in vitro antimicrobial activity against sexually transmitted pathogens, including HIV...
  9. ncbi request reprint Male tolerance of ACIDFORM gel
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 71:443-6. 2005
    ..This study was conducted to make certain that males will not be subjected to an unacceptable risk of penile irritation as a result of exposure to the product in future studies...
  10. pmc FemCap with removal strap: ease of removal, safety and acceptability
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 73:59-64. 2006
    ..This trial assessed whether the new design reduced removal difficulties and had any effects on dislodgment, genital pain/discomfort, safety, and acceptability...
  11. doi request reprint Six-day randomized safety trial of intravaginal lime juice
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    J Acquir Immune Defic Syndr 49:243-50. 2008
    ..In vitro data suggest that lime juice is virucidal, but only at cytotoxic concentrations. This is the first controlled, randomized safety trial of lime juice applied to the human vagina...
  12. pmc Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School, 1611 North Kent Street, Suite 806, Arlington 22209, USA
    Contraception 70:77-83. 2004
    ..To evaluate symptoms and signs of genital irritation, vaginal leakage and acceptability of polystyrene sulfonate (PSS), which is being studied as a vaginal contraceptive and microbicide...
  13. doi request reprint Noncomparative contraceptive efficacy of cellulose sulfate gel
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School EVMS, Arlington, Virginia 22209, USA
    Obstet Gynecol 111:739-46. 2008
    ..To estimate the 6-month cumulative probability of pregnancy, short-term adverse effects, and acceptability of cellulose sulfate vaginal contraceptive gel...
  14. ncbi request reprint Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion
    Mitchell D Creinin
    Department of Obstetrics, Gynecology, and Women s Health, University of Pittsburgh Physicians, PA, USA
    Am J Obstet Gynecol 188:664-9. 2003
    ..The purpose of this study was to evaluate the efficacy, side-effect profile, and follow-up rates in women who obtain a medical abortion in a nonresearch setting...